SPH Notice - Cooper Investors Pty Limited

100080615/3821103.1
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
Note: This form must be completed in accordance with the instructions at the end of the
form.
To NZX Limited
and
To Ryman Healthcare Limited
Relevant event being disclosed: Movement of 1% or more in substantial holding
Date of relevant event: 23 April 2025
Date this disclosure made: 24 April 2025
Date last disclosure made: 22 April 2025
Substantial product holder(s) giving disclosure
Full name(s): Cooper Investors Pty Limited (ABN 26 100 409 890) of level 12, 8 Exhibition
St, Melbourne, 3000, Victoria, Australia,
Contact details:
Jacqueline Verhaeg, Head of Compliance, (+61) 03 9660 2632 or
jverhaeg@cooperinvestors.com
Summary of substantial holding
Class of quoted voting products: Ordinary share
Summary for Cooper Investors Pty Limited
For this disclosure,—
(a) total number held in class: 67,389,505
(b) total in class: 1,015,712,784
(c) total percentage held in class: 6.6347%
For last disclosure,—
(a) total number held in class: 96,575,377
(b) total in class: 1,015,712,784
(c) total percentage held in class: 9.5081%
Details of transactions and events giving rise to relevant event

100080615/3821103.1
Details of the transactions or other events requiring disclosure: See Annexure A
Details after relevant event

Details for Cooper Investors Pty Ltd
Nature of relevant interest(s): registered holder
For that relevant interest,—
(a) number held in class: 67,389,505
(b) percentage held in class: 6.6347%
(c) current registered holder(s): that no change since last disclosure
(d) registered holder(s) once transfers are registered: N/A
For a derivative relevant interest, also—
(a) type of derivative: N/A
(b) details of derivative: N/A
(c) parties to the derivative: N/A
(d) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: N/A
Additional information
Address(es) of substantial product holder(s): N/A
Contact details: N/A
*Nature of connection between substantial product holders: N/A
*Omit if disclosure is made for only 1 substantial product holder.
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: N/A
*Disclosure has effect for purposes of directors’ and senior managers’ disclosure
N/A
*Omit if inapplicable (see section 302 of the Financial Markets Conduct Act 2013).
Certification
I, Jacqueline Verhaeg, certify that, to the best of my knowledge and belief, the
information contained in this disclosure is correct and that I am duly authorised to make
this disclosure by all persons for whom it is made.

ANNEXURE A
Trade DateTickerSecurityQuantityAmount
Curr
22-Apr-2025RYMRyman Healthcare (148,618)
$ 371,545.00 NZD
23-Apr-2025RYMRyman Healthcare (29,037,254)
$ 63,881,958.80 NZD

ANNEXURE B
Holder of Relevant InterestRegistered Holder of SecuritiesPersons entitled to be registered as holderNature of Relevant InterestNumber of Securities Persons Votes
Cooper Investors Pty LtdJP Morgan Nominees Australia Pty LtdJP Morgan Nominees Australia Pty LtdInvestment Manager6,312,598 6,312,598
Cooper Investors Pty LtdState Street Australia Limited
State Street Australia LimitedInvestment Manager9,581,690 9,581,690
Cooper Investors Pty LtdCiti Group Citi Group Investment Manager
47,492,283 47,492,283
Cooper Investors Pty LtdBNP ParibasBNP ParibasInvestment Manager4,002,934
4,002,934
Total holdings67,389,505
67,389,505
Shares Outstanding
1,015,712,784
Percentage holding6.6347%